{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:39:00Z","timestamp":1793324340837,"version":"4.5.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>T-cell exhaustion is a terminal state of immune dysfunction characterized by impaired proliferation and effector functions, diminished cytokine secretion, and sustained expression of inhibitory receptors. In coronavirus disease 2019 (COVID-19), increasing evidence links exhausted T-cell phenotypes with poor clinical outcomes, including severe disease, delayed viral clearance, and persistent symptoms associated with Long COVID. Exhaustion results from prolonged antigenic stimulation and inflammatory signals and is marked by transcriptional reprogramming, metabolic and epigenetic dysregulation, and co-expression of inhibitory receptors such as programmed cell death protein-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Notably, exhausted phenotypes in COVID-19 frequently coexist with hyperactivation, raising the unresolved question of whether inhibitory receptor expression reflects transient activation or irreversible dysfunction. Emerging therapeutic strategies to reverse these dysfunctional states include immune checkpoint inhibitors, cytokine modulation, metabolic interventions, and epigenetic therapies, although their clinical translation remains at an early stage. Critical research gaps include the scarcity of longitudinal data, incomplete profiling of T-cell subsets across disease stages during COVID-19 and Long COVID-19, and contradictory evidence of vaccine-induced exhaustion with limited understanding of its consequences. This non-systematic literature review synthesizes current advances in COVID-19 immunopathology and therapeutic strategies, underscoring that understanding T-cell exhaustion is crucial to improving outcomes and shaping next-generation immunotherapies and vaccines.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1678149","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:50Z","timestamp":1761715790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["T-cell exhaustion in COVID-19: what do we know?"],"prefix":"10.3389","volume":"16","author":[{"given":"Roderick","family":"Chen-Cama\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"L\u00f3pez-Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-coV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-coV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B8","first-page":"2018","volume-title":"Kuby immunology","author":"Punt","year":"2018"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-coV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"pbac014","DOI":"10.1093\/pcmedi\/pbac014","article-title":"Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis","volume":"5","author":"Yang","year":"2022","journal-title":"Precis Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.646688","article-title":"Immune profile in patients with COVID-19: lymphocytes exhaustion markers in relationship to clinical outcome","volume":"11","author":"Bobcakova","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01870","article-title":"Analysis of co-inhibitory receptor expression in COVID-19 infection compared to acute plasmodium falciparum malaria: LAG-3 and TIM-3 correlate with T cell activation and course of disease","volume":"11","author":"Herrmann","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe4782","article-title":"Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells","volume":"6","author":"Kusnadi","year":"2021","journal-title":"Sci Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309880","article-title":"Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity","volume":"20","author":"Asaba","year":"2025","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"114663","DOI":"10.1016\/j.intimp.2025.114663","article-title":"ScRNA-Seq reveals T cell immunity in COVID-19 patients and implications for immunotherapy","volume":"155","author":"Yao","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1034159","article-title":"Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals","volume":"13","author":"Chattopadhyay","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319322121","article-title":"The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases","volume":"121","author":"Kim","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70335","article-title":"Myeloid-driven immune suppression subverts neutralizing antibodies and T cell immunity in severe COVID-19","volume":"97","author":"Lai","year":"2025","journal-title":"J Med Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577803","article-title":"The CD38(+)HLA-DR(+) T cells with activation and exhaustion characteristics as predictors of severity and mortality in COVID-19 patients","volume":"16","author":"Long","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.09.050","article-title":"PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene","volume":"638","author":"Berger","year":"2018","journal-title":"Gene"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay4458","article-title":"Molecular mechanism of SHP2 activation by PD-1 stimulation","volume":"6","author":"Marasco","year":"2020","journal-title":"Sci Adv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100146","DOI":"10.1016\/j.cellin.2024.100146","article-title":"PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12026-014-8524-1","article-title":"Regulation of T cell responses by the receptor molecule Tim-3","volume":"59","author":"Gorman","year":"2014","journal-title":"Immunol Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","article-title":"PD-1-expressing SARS-coV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19","volume":"54","author":"Rha","year":"2021","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137799","article-title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab425","article-title":"Critically ill coronavirus disease 2019 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection","volume":"224","author":"Arcanjo","year":"2021","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012339","article-title":"IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques","volume":"20","author":"Nelson","year":"2024","journal-title":"PloS Pathog"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.1.567","article-title":"Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages","volume":"172","author":"Williams","year":"2004","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148225","article-title":"Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone","volume":"131","author":"Siska","year":"2021","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202111-2493OC","article-title":"CD4(+) T-cell dysfunction in severe COVID-19 disease is tumor necrosis factor-alpha\/tumor necrosis factor receptor 1-dependent","volume":"205","author":"Popescu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s42003-023-04730-4","article-title":"Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection","volume":"6","author":"Gurshaney","year":"2023","journal-title":"Commun Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548234","article-title":"Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies","volume":"16","author":"Nair","year":"2025","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00690-1","article-title":"Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19","volume":"23","author":"You","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154183","article-title":"Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19","volume":"7","author":"Brauns","year":"2022","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625881","article-title":"Epigenetic landscapes of single-cell chromatin accessibility and transcriptomic immune profiles of T cells in COVID-19 patients","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.focus.2023.100091","article-title":"Prevalence and characteristics of long COVID 7\u201312 months after hospitalization among patients from an urban safety-net hospital: A pilot study","volume":"2","author":"Hua","year":"2023","journal-title":"AJPM Focus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-025-02135-5","article-title":"Identification of soluble biomarkers that associate with distinct manifestations of long COVID","volume":"26","author":"Gao","year":"2025","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1502937","article-title":"Identification of an immunological signature of long COVID syndrome","volume":"15","author":"Guerrera","year":"2024","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70029","article-title":"Oral SARS-coV-2 infection and risk for long covid","volume":"35","author":"Schwartz","year":"2025","journal-title":"Rev Med Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.975980","article-title":"Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients","volume":"12","author":"Benitez Fuentes","year":"2022","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s43856-025-00829-3","article-title":"Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naive individuals with Long COVID","volume":"5","author":"Grady","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40635-024-00624-9","article-title":"Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1\/2 reactivations in critically ill patients with COVID-19","volume":"12","author":"Mattei","year":"2024","journal-title":"Intensive Care Med Exp"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect Dis Now"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06716-y","article-title":"Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality","volume":"48","author":"Gatto","year":"2022","journal-title":"Intensive Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13054-021-03843-8","article-title":"HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients","volume":"25","author":"Meyer","year":"2021","journal-title":"Crit Care"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/jof9030315","article-title":"Pulmonary aspergillosis in critically ill COVID-19 patients admitted to the intensive care unit: A retrospective cohort study","volume":"9","author":"Bergmann","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/jof9010086","article-title":"Invasive fungal infections in hospitalized patients with COVID-19: A non-intensive care single-centre experience during the first pandemic waves","volume":"9","author":"Cattaneo","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T cells from patients with Candida sepsis display a suppressive immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit Care"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146701","article-title":"PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response","volume":"6","author":"Loretelli","year":"2021","journal-title":"JCI Insight"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41467-020-15025-1","article-title":"TIGIT limits immune pathology during viral infections","volume":"11","author":"Schorer","year":"2020","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329","article-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","volume":"384","author":"Mathew","year":"2024","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.189150","article-title":"A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19","volume":"10","author":"Shankar-Hari","year":"2025","journal-title":"JCI Insight"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677008","article-title":"Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action","volume":"12","author":"Islam","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","article-title":"A potential role of interleukin 10 in COVID-19 pathogenesis","volume":"42","author":"Lu","year":"2021","journal-title":"Trends Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"102999","DOI":"10.1016\/j.ebiom.2020.102999","article-title":"Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study","volume":"60","author":"Masia","year":"2020","journal-title":"EBioMedicine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"CD013881","DOI":"10.1002\/14651858.CD013881.pub2","article-title":"Interleukin-6 blocking agents for treating COVID-19: a living systematic review","volume":"6","author":"Ghosn","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"106241","DOI":"10.1016\/j.jinf.2024.106241","article-title":"The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19","volume":"89","author":"Gottlieb","year":"2024","journal-title":"J Infect"},{"key":"B72","doi-asserted-by":"publisher","first-page":"137836","DOI":"10.1016\/j.ijbiomac.2024.137836","article-title":"The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis","volume":"284","author":"Behzadi","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cytogfr.2024.10.001","article-title":"The yin and yang of TLR4 in COVID-19","volume":"82","author":"Mukherjee","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1038\/s41598-024-67028-3","article-title":"A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX)","volume":"14","author":"Arulkumaran","year":"2024","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00994-9","article-title":"Plasma exchange to rescue patients with autoantibodies against type I interferons and life-threatening COVID-19 pneumonia","volume":"41","author":"de Prost","year":"2021","journal-title":"J Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41598-022-25930-8","article-title":"Impact of plasmapheresis on severe COVID-19","volume":"13","author":"Fonseca-Gonzalez","year":"2023","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1492672","article-title":"Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19","volume":"15","author":"Guironnet-Paquet","year":"2024","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1alpha-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/jbcpp-2020-0495","article-title":"A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19","volume":"33","author":"Mashayekhi-Sardoo","year":"2021","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"108183","DOI":"10.1016\/j.diabres.2020.108183","article-title":"Metformin in COVID-19: A possible role beyond diabetes","volume":"164","author":"Sharma","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185489","article-title":"Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivo","volume":"135","author":"Mu","year":"2025","journal-title":"J Clin Invest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.bbih.2024.100733","article-title":"Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19","volume":"36","author":"Isman","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01224-z","article-title":"Epigenetic regulation of T cell exhaustion","volume":"23","author":"Belk","year":"2022","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41590-021-01057-2","article-title":"Author Correction: Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.841716","article-title":"HDAC inhibition as potential therapeutic strategy to restore the deregulated immune response in severe COVID-19","volume":"13","author":"Ripamonti","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh0272","article-title":"Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity","volume":"13","author":"Prinzing","year":"2021","journal-title":"Sci Transl Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597417","article-title":"Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants","volume":"16","author":"Jeon","year":"2025","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn2688","article-title":"Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1\/mRNA-1273 vaccination","volume":"375","author":"Kaku","year":"2022","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","first-page":"109664","DOI":"10.1016\/j.celrep.2021.109664","article-title":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2","volume":"36","author":"Dangi","year":"2021","journal-title":"Cell Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2527438","DOI":"10.1080\/21645515.2025.2527438","article-title":"A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants","volume":"21","author":"Vahed","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1038\/s41598-023-31347-8","article-title":"Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination","volume":"13","author":"Tavukcuoglu","year":"2023","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931039","article-title":"T cell perturbations persist for at least 6 months following hospitalization for COVID-19","volume":"13","author":"Govender","year":"2022","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae180","article-title":"Rapid progression of CD8 and CD4 T cells to cellular exhaustion and senescence during SARS-CoV2 infection","volume":"116","author":"Pedroso","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676932","article-title":"Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health","volume":"12","author":"Townsend","year":"2021","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9105","article-title":"SARS-CoV-2 infection generates tissue-localized immunological memory in humans","volume":"6","author":"Poon","year":"2021","journal-title":"Sci Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.immuni.2021.06.002","article-title":"Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions","volume":"54","author":"Schwabenland","year":"2021","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"115907","DOI":"10.1016\/j.celrep.2025.115907","article-title":"Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters","volume":"44","author":"da Silva Antunes","year":"2025","journal-title":"Cell Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1038\/s41467-025-60216-3","article-title":"No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations","volume":"16","author":"Benoit","year":"2025","journal-title":"Nat Commun"},{"key":"B101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s42003-023-04447-4","article-title":"Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity","volume":"6","author":"Park","year":"2023","journal-title":"Commun Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1678149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:51Z","timestamp":1761715791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1678149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":101,"alternative-id":["10.3389\/fimmu.2025.1678149"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1678149","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1678149"}}